UM

Browse/Search Results:  1-1 of 1 Help

Selected(0)Clear Items/Page:    Sort:
iRGD decorated lipid-polymer hybrid nanoparticles for targeted co-delivery of doxorubicin and sorafenib to enhance anti-hepatocellular carcinoma efficacy Journal article
Zhang J., Hu J., Chan H.F., Skibba M., Liang G., Chen M.. iRGD decorated lipid-polymer hybrid nanoparticles for targeted co-delivery of doxorubicin and sorafenib to enhance anti-hepatocellular carcinoma efficacy[J]. Nanomedicine: Nanotechnology, Biology, and Medicine, 2016, 12(5), 1303.
Authors:  Zhang J.;  Hu J.;  Chan H.F.;  Skibba M.;  Liang G.; et al.
Favorite | TC[WOS]:95 TC[Scopus]:105 | Submit date:2018/10/30
Active Targeting  Doxorubicin  Hepatocellular Carcinoma  Irgd Peptide  Sorafenib